ALPHACENTRIC ADVISORS LLC Sage Therapeutics, Inc. Transaction History

ALPHACENTRIC ADVISORS LLC portfolio value:

$0
portfolio value

ALPHACENTRIC ADVISORS LLC quarter portfolio value change:

-9.46%
quarter

Sage Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -11K shares -468K $39.16 0
Q4 2021 share Increase +83.33% 5K shares 202K $43.25 11K
Q3 2021 share Increase 0.00% 6K shares 266K $44.31 6K